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Abstract 
New hyaluronic acid–itaconic acid films were synthesized as potential materials 
with biomedical applications. In this work, we explored the homogeneous cross-
linking reactions of hyaluronic acid using glutaraldehyde in the presence of 
itaconic acid and triacetin as plasticizers. 
Biomechanical properties were assessed in terms of stability by measuring 
swelling in aqueous environments, investigating wettability using contact angle 
tests, and evaluating bioadhesive performance. The ductility of the materials 
was evaluated through stress-strain measurements and the morphology was 
explored by scanning electron microscopy. 
The results show that the incorporation of itaconic acid improved most of the 
desirable properties, increasing adhesiveness and reducing wettability and 
swelling. The use of triacetin enhanced the strength, bioadhesiveness, and 
ductility of the material.  
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Introduction 
The hyaluronic acid (HA), also known as hyaluronan, is a naturally occurring high 
molecular mass linear biopolymer, consisting of alternating units of N-acetyl-β-D-
glucosamine and β-D-glucuronic acid. It is a biodegradable, biocompatible, non-toxic, non-
immunogenic and non-inflammatory biomaterial [1]. The total amount of HA in the adult 
human has been estimated to be 11–17 g [2]. It is distributed throughout the human body, 
forming part of the synovial fluid and the extracellular matrix of biological tissues such as 
the skin, umbilical cord and vitreous humor. In medical practice, HA is widely used in many 
pathological conditions such as osteoarthritis [3], wound repair [4] and eye surgery [5].  
HA has excellent water-binding capacity, responsible for retaining moisture in the eyes, 
joints and skin [6]. Dissolution of this biopolymer results in a highly viscous gel with unique 
viscoelastic properties, which enable its use in orthopedics [7]. Many studies have been 
performed to formulate HA in an injectable form [8], which can be used to treat 
osteoarthritis of the knee [9]. Several HA derivatives have been developed for drug 
delivery [10], mainly for its potential as a biodegradable carrier [11]. Some authors have 
reported the use of this polymer for different proteins, drugs [12], peptides [13] or for gene 
delivery [14, 15] using HA as a depot system [16], as hydrogels (physically and chemically 
cross-linked) [17–19] or as nano- or micro-particulate systems [20, 21]. Studies related to 
biocompatibility and biodegradability [22] have supported the use of HA as a promising 
biomaterial to design modified drug delivery systems. 
The poor stability of HA in living tissues and fast dissolution in water make some 
modifications necessary to overcome these drawbacks. Cross-linking reactions have been 
carried out in order to improve HA properties, leading to more robust materials. Hetero-
geneous cross-linking methods have been reported, where reactions were carried out on 
previously casted solid HA films or membranes, using glutaraldehyde (GTA) as the cross-
linker [23]. However, this processes not only improves the strength of the cross-linked 
materials, it also makes them more rigid and fragile (brittle). Further techniques as well as 
polymer interpenetration have also been reported [24, 25]. 
In this work, we explored chemical modifications to the HA backbone by a homogeneous 
cross-linking reaction between HA and GTA in the presence of itaconic acid (IT), a 
naturally occurring compound that is non-toxic, and readily biodegradable. The homo-
geneous reaction was achieved by adding the cross-linker agents to the HA solution, 
obtaining a final cross-linked film after casting. 
To mitigate the fragility of cross-linked films, triacetin (TA) was assessed as a potential 
plasticizer in order to obtain more ductile materials. The stability of the materials in 
aqueous medium was evaluated through swelling and water affinity was studied using 
contact angle assays. The ductility and bioadhesive force were appraised through stress-
strain tests. In addition, the morphology was studied by scanning electron microscopy 
(SEM). 
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Experimental 
Materials 
Hyaluronic acid sodium salt (Mw: 1,560,000 Da) was obtained from Parafarm® (Buenos 
Aires, Argentina), itaconic acid for synthesis was provided by Merck Schuchardt OHG 
(Hohenbrunn, Germany), and glutaraldehyde (25% in H2O) and porcine mucin were 
purchased from Sigma-Aldrich Corp. (St. Louis, MO, USA). All other chemicals were of 
extra pure reagent grade and used as received. 
Film Synthesis 
Four HA systems (Table 1) were synthesized from HA/GTA, HA/IT/GTA and HA/GTA + TA 
solutions, using bi-distilled water as the solvent. The amount of each reactant was set to 
achieve (1:2) and (1:4) HA/GTA molar ratios, or (1:1:2) in the case of the HA/IT/GTA 
solutions. All HA concentrations were adjusted to 1% (w/w). The plasticizer, TA, was used 
in order to attain 20% of the solid weight of the final film. 
Cross-linking reactions were accomplished under acidic conditions; the pH value was 
adjusted to 3.7 with 0.01 M HCl. After 24 h of reaction time under slight stirring at room 
temperature (RT), the obtained gels were cast at RT under an extractor hood. Different 
sized Petri dishes were used to obtain a variety of film thicknesses. 
Tab. 1.  Composition of films (molar ratios) 
Formulation HA GTA IT TA* 
HA film 1 – – – 
1:2 film 1 2 – – 
1:4 film 1 4 – – 
IT film 1 2 1 – 
TA film 1 2 – 20% 
* % Weight of final film. 
 
Contact Angle Measurements 
The wetting behavior of film surfaces was characterized by the contact angle (CA) method. 
Measurements were conducted with an Easy Drop DSA goniometer from Kruss GmbH 
(Hamburg, Germany), using a distilled water drop at RT. 
An imaging system was used to measure the CA; the shape and size of water droplets on 
the tested surfaces of films was measured by digital image analysis software. The CA from 
the images was measured 5 sec after a 5 μL droplet of distilled water was placed on the 
sample surface. Three samples (n=3) from each film were used for CA measurements.  
Film Swelling  
The determination of swelling behavior of the films was carried out by adapting the method 
described by Llabot et al. [26]. Cross-linked films were tested in distilled water at RT after 
sample drying to achieve a constant weight (n = 3 in triplicate). The swelling ratio (SR) was 
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calculated using the equation: SR = Ws/Wd, where Ws is the weight of the sample at 
equilibrium at each temperature and Wd is the weight of the dried sample. 
Mucoadhesion and Stress-Strain  
The adhesive bond was measured in terms of the strength needed to separate or break 
the adhesive bonds between the matrix and the biological substrate. Samples were 
attached to a holder with cyanoacrylate-based glue, and the support was suspended from 
a spring placing the free surface of the film in direct contact with the biological substrate, 
after pre-wetting of the area with 50 µl of water. A force of 20 grams was applied for 30 
seconds before performing the measurement on an adapted Jolly balance. As the 
biological substrate, a 30% (w/v) porcine gastric mucin gel was used. 
The stress-strain properties of the films were studied using sample strips of 1 x 5 cm (n = 
10) on an Instron 3369 tester (Norwood, USA) in traction mode at 2 mm/min at RT (23°C). 
Morphological Characterization  
The surface morphology of samples was examined by SEM (Leo EVO-40XVP from Carl 
Zeiss AG, Oberkochen, Germany). The samples were swelled in distilled water for a 
certain period of time at room conditions. Subsequently, they were freeze dried and coated 
with Au in a PELCO 91000 sputter coater before observation. 
Statistical Analysis  
The results of the experiments are expressed as mean ± standard error. Differences were 
considered to be significant when p ≤ 0.05. Significant differences were determined by 
Student’s t-test. 
Results and Discussion 
Contact Angle and Swelling 
CA values are presented in Figure 1. Significant differences (p < 0.05) were found 
between all groups. The data show an increase in CA when the GTA concentration was 
higher in the film (1:2 film and 1:4 film). Similarly findings were observed when TA 
(hydrophobic plasticizer) and IT were added; the presence of TA led to a greater CA, 
evidencing an increase in this parameter which shows that these compounds directly 
affect the interaction between the system and the surrounding aqueous environment. 
Swelling measurements (Figure 2) are useful to evaluate the stability and cross-linking rate 
of films. Although, as shown in Figure 1, the use of a higher cross-linker concentration led 
to materials with reduced wettability, the swelling studies showed poor stability for these 
formulations in aqueous media (considerable swelling). On the other hand, the presence of 
TA in the film led to similar behavior with respect to the same formulation without the 
plasticizer (1:2 film). The films containing IT in the formulation had the lowest swelling ratio 
and the highest CA measurements, suggesting that IT increases the cross-linking ratio 
between HA chains. Moreover, the trend showed by the IT films regarding swelling 
behavior suggests lower water contents than those reported by Tomihata et al., i.e. 60% 
after 24 h of swelling in PBS for heterogeneous HA cross-linked films [23]. 
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Fig. 1.  CA values for different cross-linked HA films 
 
Fig. 2.  Swelling ratio of cross-linked HA films immersed in distilled water at RT 
Mucoadhesion, Stress-Strain and Morphological Characterization 
The adhesive strength of each formulation is shown in Table 2. An evident increase in 
mucoadhesion was observed when HA was cross-linked with GTA. The addition of both IT 
and TA also improved the adhesion strength.  
The higher increase obtained with TA was attributed to the rise in chain mobility favored by 
the presence of the plasticizer, which contributed to the interaction between HA and mucin 
chains. In general, the introduction of a cross-linker results in a higher Tg, which in turn 
decreases bioadhesion through a decrease in chain mobility and interpenetration [27]. 
However, in our case, the bioadhesive force of the HA cross-linked films was increased. 
This can be attributed to the fact that increased cross-linking density results in less 
swelling, leading to a greater number of carboxyl groups in a given surface area for 
bioadhesion. Thus, the formation of secondary hydrogen bonds is facilitated [28]. 
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Stress-strain studies (Figure 3) revealed a marked change in the tensile behavior of the 
cross-linked films, changing from ductile to brittle; in fact, these films broke before reaching 
the yield point. In contrast, cross-linked films containing TA exhibited plastic deformation. 
Although the cross-linking process led to increased polymer rigidity as a result of the 
restrained movements of the polymer molecules, the presence of TA mitigated these 
effects. Hence, the presence of TA gives the possibility of cross-linking HA without losing 
flexibility. 
Tab. 2.  Mucoadhesive strength  
Sample Mucoadh. (kgf/cm2) ± SD 
HA film 153.24 ±26.32 
1:2 film 198.78± 26.39* 
1:4 film 226.74± 15.03* 
IT film 213.44 ±18.08* 
TA film 220.43±14.47* 
* p < 0.05 compared to the HA film. 
 
 
Fig. 3.  Stress-strain assay of cross-linked films at RT 
The SEM images (Figure 4) show the surface structure of the swelled films. All formulated 
cross-linked films showed a porous structure after swelling in aqueous media. This 
property could be of interest for scaffolds and tissue engineering purposes. 
The importance of new biomaterials for medical applications is observed in a consistently 
growing research literature [29–34]. Most current research efforts are focused in the 
development of biomaterials from naturally occurring polymers [35–39]. However, many of 
these materials have poor biomechanical properties and insufficient stability in aqueous 
environments and living tissues. Thus, the need for more robust and stable materials has 
led to the study of different structural modifications on its backbone. 
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The results obtained in this study clearly show that cross-linking HA affects system 
interactions with the surrounding aqueous medium. The contact angle and swelling 
measurements shown in Figures 1 and 2 demonstrate that cross-linking of HA chains 
provided insoluble matrices capable of taking up water inside its structure without losing 
stability. Similar findings have been reported for HA [10, 23, 40] and other natural 
biopolymers like chitosan [41, 42], alginate [43, 44] and collagen [45]. 
 
Fig. 4.  SEM pictures of swelled a) 1:2 film (200x), b) 1:4 film (200x), c) IT film (300x) 
and d) TA film (300x) 
Some desirable properties of natural biomaterials like biocompatibility, biodegradability, 
ductility and bioadhesiveness can be altered after chemical structural modifications. 
Ductile behavior not only guarantees better handling of the material but also makes it more 
suitable and adaptable to living tissues; this is complemented by the ability to remain 
attached to the mucosal layers of tissues. The results of this work confirm that cross-
linking chemical reactions increase the sturdiness of biopolymers like HA but often lead to 
more fragile materials. However, the use of appropriate plasticizers can overcome these 
drawbacks [46, 47] and also improve other properties like bioadhesion. 
Previous reports have noted the toxicity of GTA [48], which can be avoided by extensive 
washing [10] or inactivation [49]. 
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Conclusion 
The use of GTA as a cross-linking agent significantly improved the integrity and the 
bioadhesiveness of HA films in aqueous environments. Cross-linked polymers showed 
more stability and increased porosity when the material had swelled. 
Incorporation of IT improved most of the desirable properties studied for the HA/GTA 
systems, i.e. it increased adhesiveness and reduced wettability and swelling, but also 
made the original material more fragile. On the other hand, the use of TA as a plasticizer 
not only enhanced the strength and the bioadhesiveness of the material, but also made it 
more ductile and less rigid. The use of GTA as a cross-linker was found to be effective at 
improving HA properties; however, more studies should be performed regarding toxicity. 
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